Current Trials available at Adelaide Oncology & Haematology

Tumour Type

Trial

  Principal    Investigator


   Title

Melanoma         

PISCES             

   Dr Rachel                 Roberts-  Thomson

  A Multicentre Phase 2,    Open-Label Study of    Intratumoral   TavokinogeneTelseplasmid   (tavo, pIL-12)   plus Electroporation in   Combination with    Intravenous    Pembrolizumab in Patients with Stage III/IV Melanoma who are Progressing on either Pembrolizumab or Nivolumab Treatment

TNBC                

OMS- I141      

   Dr Rohit Joshi

A phase 2, open-label study of intratumoural Tavokinogene Telseplasmid plus electroporation in combination with intravenous Pembrolizumab therapy in patients with inoperable locally advanced or metastatic triple negative breast cancer.

NSCLC

Pacific-R

   Dr Rohit Joshi

First real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (Retrospective data collection from patients treated with durvalumab via EAP)

Lymphoma  

Gilead      

   Dr Wilfrid Jaksic

Dose optimazation of Idelalisib in follicular lymphoma

TRIAL CURRENTLY ON HOLD